biopharma-report - PitchBook

Biopharma Quarterly

More news about this topic

Biopharma Quarterly

Biopharma VC Trends

April 28, 2026

Biopharma VC deal value fell to $7.2 billion in Q1 2026 as capital shifted toward exits. We examine modality trends, oncology, and obesity deal flow, and what a strengthening exit environment means for 2026.

Research

Learn more »
Biopharma Quarterly

Biopharma VC Trends

February 13, 2026

The Q4 2024 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Biopharma Quarterly

Biopharma VC Trends

November 5, 2025

The Q3 2025 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Biopharma Quarterly

Biopharma VC Trends

August 5, 2025

The Q2 2025 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Biopharma Quarterly

Biopharma Modalities VC Trends

May 15, 2025

The Q1 2025 Biopharma Modalities VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Biopharma Quarterly

Biopharma Modalities VC Trends

March 11, 2025

The Q4 2024 Biopharma Modalities VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Private Equity

RFK Jr. nomination dents PE confidence in CRO market

December 12, 2024

Vaccine scrutiny could raise clinical trial standards, which poses a risk to fund managers with significant investments in CROs.

Article

Learn more »
Healthcare

Biopharma Report

November 18, 2024

The Q3 2024 Biopharma Report provides an overview of industry trends and includes a market map of VC-backed companies. Innovation spotlights include radiopharmaceuticals and AI protein engineering.

Research

Learn more »
Healthcare

Biopharma Report

August 21, 2024

The Q2 2024 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthcare

Biopharma Report

June 4, 2024

The Q1 2024 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthcare

Biopharma Report

March 3, 2024

The Q4 2023 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthcare

Launch Report: Biopharma

December 5, 2023

The Q3 2023 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

Research

Learn more »